FDA recall, , High risk
Baxter Duo-Vent Solution Set and Male Luer Lock Adapter
The Baxter Duo-Vent Solution Set and Male Luer Lock Adapter can have air bubbles in the drip chamber and tubing.
What happened
Baxter Healthcare Corporation, of Deerfield, Illinois, recalled the Baxter Duo-Vent Solution Set and Male Luer Lock Adapter, Product Code 1C8507, a solution administration set, because Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position. The recall began on June 30, 2026, and was added to the FDA's Enforcement Report on August 11, 2026.
The recalled product was distributed nationwide in the US, with no consignees outside the US.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is your set affected?
Match the UDI-DI and lot code listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Baxter Duo-Vent Solution Set and Male Luer Lock Adapter, Product Code 1C8507; Solution Administration Sets
- UDI-DI
- 00085412014319
- Lot code
- DR26C27062
- 30-MAR-2028
Recall details
- Company began the recall
- Sold in
US Nationwide. No OUS consignees.
- Company
- Baxter Healthcare CorporationDeerfield, Illinois
- Hazard
- Device defect
- Risk
High risk
There is a reasonable chance that using it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 99343
- Recall number
- Z-2766-2026
- Quantity recalled
- 24528 units
All recalls from Baxter Healthcare Corporation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated



